Notice of Award of a Single-Source Cooperative Agreement To Fund National Institute for Communicable Diseases (NICD), South Africa, 3541-3542 [2022-01271]

Download as PDF 3541 Federal Register / Vol. 87, No. 15 / Monday, January 24, 2022 / Notices two thresholds are met. Competitor corporations are covered by Section 8 if each one has capital, surplus, and undivided profits aggregating more than $10,000,000, with the exception that no corporation is covered if the competitive sales of either corporation are less than $1,000,000. Section 8(a)(5) requires the Federal Trade Commission to revise those thresholds annually, based on the change in gross national product. The new thresholds, which take effect immediately, are $41,034,000 for Section 8(a)(1), and $4,103,400 for Section 8(a)(2)(A). DATES: January 24, 2022. FOR FURTHER INFORMATION CONTACT: Christopher M. Grengs, (202–326–2612), Bureau of Competition, Office of Policy and Coordination. Authority: 15 U.S.C. 19(a)(5). April J. Tabor, Secretary. [FR Doc. 2022–01215 Filed 1–21–22; 8:45 am] BILLING CODE 6750–01–P FEDERAL TRADE COMMISSION Revised Jurisdictional Thresholds for Section 7A of the Clayton Act Federal Trade Commission. Notice. AGENCY: ACTION: The Federal Trade Commission announces the revised thresholds for the Hart-Scott-Rodino Antitrust Improvements Act of 1976 required by the 2000 amendment of Section 7A of the Clayton Act. DATES: February 23, 2022. FOR FURTHER INFORMATION CONTACT: Nora Whitehead (202–326–3100), Bureau of Competition, Premerger Notification Office, 400 7th Street SW, Room 5301, Washington, DC 20024. SUPPLEMENTARY INFORMATION: Section 7A of the Clayton Act, 15 U.S.C. 18a, as added by the Hart-Scott-Rodino Antitrust Improvements Act of 1976, Public Law 94–435, 90 Stat. 1390 (‘‘the Act’’), requires all persons SUMMARY: contemplating certain mergers or acquisitions, which meet or exceed the jurisdictional thresholds in the Act, to file notification with the Commission and the Assistant Attorney General and to wait a designated period of time before consummating such transactions. Section 7A(a)(2) requires the Federal Trade Commission to revise those thresholds annually, based on the change in gross national product, in accordance with Section 8(a)(5). Note that while the filing fee thresholds are revised annually, the actual filing fees are not similarly indexed and, as a result, have not been adjusted for inflation in over a decade. The new thresholds, which take effect 30 days after publication in the Federal Register, are as follows: Original threshold (million) Subsection of 7A 7A(a)(2)(A) ................................................................................................................................................. 7A(a)(2)(B)(i) .............................................................................................................................................. 7A(a)(2)(B)(i) .............................................................................................................................................. 7A(a)(2)(B)(ii)(i) .......................................................................................................................................... 7A(a)(2)(B)(ii)(i) .......................................................................................................................................... 7A(a)(2)(B)(ii)(II) ........................................................................................................................................ 7A(a)(2)(B)(ii)(II) ........................................................................................................................................ 7A(a)(2)(B)(ii)(III) ....................................................................................................................................... 7A(a)(2)(B)(ii)(III) ....................................................................................................................................... Section 7A note: Assessment and Collection of Filing Fees 1 (3)(b)(1) ................................................... Section 7A note: Assessment and Collection of Filing Fees (3)(b)(2) ..................................................... Section 7A note: Assessment and Collection of Filing Fees (3)(b)(2) ..................................................... Section 7A note: Assessment and Collection of Filing Fees (3)(b)(3) ..................................................... 1 Public $403.9. 101. 403.9. 20.2. 202. 20.2. 202. 202. 20.2. 202. 202. 1.0098 billion. 1.0098 billion. Law 106–553, Sec. 630(b) amended Sec. 18a note. Any reference to these thresholds and related thresholds and limitation values in the HSR rules (16 CFR parts 801–803) and the Antitrust Improvements Act Notification and Report Form (‘‘the HSR Form’’) and its Instructions will also be adjusted, where indicated by the term ‘‘(as adjusted)’’, as follows: Original threshold jspears on DSK121TN23PROD with NOTICES1 $200 50 200 10 100 10 100 100 10 100 100 500 500 Adjusted threshold (million) $10 million .............. $50 million .............. $100 million ............ $110 million ............ $200 million ............ $500 million ............ $1 billion ................. Adjusted threshold $20.2 million. $101 million. $202 million. $222.2 million. $403.9 million. $1.0098 billion. $2.0196 billion. By direction of the Commission. April J. Tabor, Secretary. [FR Doc. 2022–01214 Filed 1–21–22; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Award of a Single-Source Cooperative Agreement To Fund National Institute for Communicable Diseases (NICD), South Africa Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: VerDate Sep<11>2014 18:11 Jan 21, 2022 Jkt 256001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $5,000,000 for Year 1 of funding to the National Institute for Communicable Diseases (NICD), South Africa. The award will provide accurate, timely, and highquality strategic information to enable the South African Government (SAG) to track critical infectious disease pathogens, monitor interventions, and inform policy and programming to reduce disease transmission and burden. Annual award amounts for years 2–5 will be set at continuation. DATES: The period for this award will be September 30, 2022, through September 29, 2027. FOR FURTHER INFORMATION CONTACT: Dr. Karidia Diallo, Center for Global Health, Centers for Disease Control and SUMMARY: E:\FR\FM\24JAN1.SGM 24JAN1 3542 Federal Register / Vol. 87, No. 15 / Monday, January 24, 2022 / Notices Prevention, 100 Totius Street, Groenkloof, Pretoria, South Africa, Telephone: 800–232–6348, Email: edu9@cdc.gov. DEPARTMENT OF HEALTH AND HUMAN SERVICES The single-source award will support the SAG in four broad areas of public health surveillance and response: Communicable (e.g., HIV and TB) and non-communicable disease surveillance, public health laboratory capacity, public health workforce development, and global health security. The NICD, under the National Public Health Institute of South Africa (NAPHISA), is in a unique position to conduct this work, through an act of parliament mandating the organization to provide microbiology, virology, epidemiology, surveillance and public health research and training to support the government’s response to communicable disease threats. SUPPLEMENTARY INFORMATION: Summary of the Award Recipient: National Institute for Communicable Diseases (NICD), South Africa. Purpose of the Award: The purpose of this award is to provide accurate, timely, and high-quality strategic information to enable the SAG to track critical infectious disease pathogens, monitor interventions, and inform policy and programming to reduce disease transmission and burden. Amount of Award: The approximate year 1 funding amount will be $5,000,000 in Federal Fiscal Year (FFY) 2022 funds, subject to the availability of funds. Annual award amounts for years 2–5 will be set at continuation. Authority: This program is authorized under Public Law 108–25 (the United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act of 2003). Period of Performance: September 30, 2022, through September 29, 2027. Dated: January 19, 2022. Terrance Perry, Chief Grants Management Officer, Centers for Disease Control and Prevention. [FR Doc. 2022–01271 Filed 1–21–22; 8:45 am] jspears on DSK121TN23PROD with NOTICES1 BILLING CODE 4163–18–P VerDate Sep<11>2014 18:11 Jan 21, 2022 Jkt 256001 Centers for Disease Control and Prevention [60Day–22–22BY; Docket No. CDC–2022– 0008] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Importation Regulations (42 CFR 71 subpart F), which specifies the requirements for importing animals or animal products that are regulated by CDC into the United States. DATES: CDC must receive written comments on or before March 25, 2022. ADDRESSES: You may submit comments, identified by Docket No. CDC–2022– 0008 by any of the following methods: • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21–8, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to Regulations.gov. Please note: Submit all comments through the Federal eRulemaking portal (regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21–8, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) SUMMARY: PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses; and 5. Assess information collection costs. Proposed Project Importation Regulations (42 CFR 71 Subpart F)—New—National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC). Background and Brief Description This is a request for a new information collection to consolidate forms and information collections related to the importation of animals, animal products, and human remains into one information collection. This information collection was previously part of three separate, OMB-approved information collections: (1) 0920–1034 (expires 3/31/2022), (2) 0920–0263 (expires 9/30/2023), and (3) 0920–0199 (expires 8/31/2024). CDC is requesting a three-year OMB clearance for this new, combined information collection. Section 361 of the Public Health Service Act (PHSA) (42 U.S.C. 264) E:\FR\FM\24JAN1.SGM 24JAN1

Agencies

[Federal Register Volume 87, Number 15 (Monday, January 24, 2022)]
[Notices]
[Pages 3541-3542]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01271]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Award of a Single-Source Cooperative Agreement To Fund 
National Institute for Communicable Diseases (NICD), South Africa

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), located 
within the Department of Health and Human Services (HHS), announces the 
award of approximately $5,000,000 for Year 1 of funding to the National 
Institute for Communicable Diseases (NICD), South Africa. The award 
will provide accurate, timely, and high-quality strategic information 
to enable the South African Government (SAG) to track critical 
infectious disease pathogens, monitor interventions, and inform policy 
and programming to reduce disease transmission and burden. Annual award 
amounts for years 2-5 will be set at continuation.

DATES: The period for this award will be September 30, 2022, through 
September 29, 2027.

FOR FURTHER INFORMATION CONTACT: Dr. Karidia Diallo, Center for Global 
Health, Centers for Disease Control and

[[Page 3542]]

Prevention, 100 Totius Street, Groenkloof, Pretoria, South Africa, 
Telephone: 800-232-6348, Email: [email protected].

SUPPLEMENTARY INFORMATION: The single-source award will support the SAG 
in four broad areas of public health surveillance and response: 
Communicable (e.g., HIV and TB) and non-communicable disease 
surveillance, public health laboratory capacity, public health 
workforce development, and global health security. The NICD, under the 
National Public Health Institute of South Africa (NAPHISA), is in a 
unique position to conduct this work, through an act of parliament 
mandating the organization to provide microbiology, virology, 
epidemiology, surveillance and public health research and training to 
support the government's response to communicable disease threats.

Summary of the Award

    Recipient: National Institute for Communicable Diseases (NICD), 
South Africa.
    Purpose of the Award: The purpose of this award is to provide 
accurate, timely, and high-quality strategic information to enable the 
SAG to track critical infectious disease pathogens, monitor 
interventions, and inform policy and programming to reduce disease 
transmission and burden.
    Amount of Award: The approximate year 1 funding amount will be 
$5,000,000 in Federal Fiscal Year (FFY) 2022 funds, subject to the 
availability of funds. Annual award amounts for years 2-5 will be set 
at continuation.
    Authority: This program is authorized under Public Law 108-25 (the 
United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act 
of 2003).
    Period of Performance: September 30, 2022, through September 29, 
2027.

    Dated: January 19, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-01271 Filed 1-21-22; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.